ロード中...
Protective effect of p-coumaric acid against doxorubicin induced toxicity in H9c2 cardiomyoblast cell lines
Doxorubicin (Dox) has been used for more than four decades to treat cancer, particularly solid tumours and haematological malignancies. However, the administration of this drug is a matter of concern in the clinical community, since Dox therapy is commonly associated with dose-dependent cardiotoxici...
保存先:
| 出版年: | Toxicol Rep |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5598262/ https://ncbi.nlm.nih.gov/pubmed/28962464 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.toxrep.2015.08.002 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|